References
Jan 30, 1988·British Medical Journal
Oct 7, 1988·Science·S E D'SouzaE F Plow
Apr 7, 1994·The New England Journal of Medicine·UNKNOWN EPIC Investigators
Nov 16, 1996·Lancet·UNKNOWN CAPRIE Steering Committee
Feb 1, 1997·Proceedings of the Society for Experimental Biology and Medicine·L T Kim, K M Yamada
Jun 12, 1997·The New England Journal of Medicine·UNKNOWN EPILOG Investigators
Mar 26, 1998·Journal of Cardiovascular Pharmacology·J L MehtaT G Saldeen
May 20, 1998·Circulation·M A MascelliR E Jordan
May 23, 1998·The New England Journal of Medicine·UNKNOWN Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS)
May 23, 1998·The New England Journal of Medicine·UNKNOWN Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators
Jul 21, 1998·Journal of the American College of Cardiology·C M GibsonS B King
Aug 15, 1998·The New England Journal of Medicine·UNKNOWN Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigato
Dec 1, 1998·Circulation·L A HarkerJ M Herbert
Dec 5, 1998·Toxicon : Official Journal of the International Society on Toxinology·F S Markland
Dec 19, 1998·Journal of the American College of Cardiology
Jan 8, 1999·Drugs·K J McClellan, K L Goa
Feb 6, 1999·Journal of the American College of Cardiology·R N PianaJ A Bittl
Apr 3, 1999·Drugs·M Dooley, K L Goa
Apr 3, 1999·Medicinal Research Reviews·P E Sanderson
May 5, 1999·Circulation·M QuinnD Fitzgerald
May 13, 1999·Biochimica Et Biophysica Acta·Y YokotaH Arita
May 18, 1999·Thrombosis Research·M ElgS Carlsson
Sep 29, 1999·American Heart Journal·J E Tcheng
Nov 7, 1999·Journal of the American College of Cardiology·F J NeumannA Schömig
Nov 11, 1999·Circulation·S R SteinhublA M Lincoff
Dec 10, 1999·Shock·S H BaekK B Kwun
Mar 23, 2000·Toxicon : Official Journal of the International Society on Toxinology·K ZhaoZ Lin
May 4, 2000·The New England Journal of Medicine·W W O'NeillR Anders
Jul 13, 2000·Circulation·C P CannonE Braunwald
Aug 10, 2000·Circulation·M E BertrandUNKNOWN CLASSICS Investigators
Sep 7, 2000·The American Journal of Medicine·M A MemonF J Menapace
Sep 12, 2000·Current Cardiology Reports·S R Hankins, E M Horn
Sep 15, 2000·Journal of the American College of Cardiology·D HasdaiD R Holmes
Oct 14, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·C KupattP Boekstegers
Oct 29, 2000·British Journal of Haematology·R F StoreyS Heptinstall
Nov 4, 2000·Expert Opinion on Investigational Drugs·M ErikssonA Nordgren
Jan 6, 2001·Lancet·UNKNOWN ESPRIT Investigators. Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy
Mar 3, 2001·Thrombosis Research·C H WuJ R Sheu
Mar 10, 2001·The New England Journal of Medicine·G R BernardUNKNOWN Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group
Apr 27, 2001·Expert Opinion on Investigational Drugs·T SteinmetzerJ Sturzebecher
May 1, 2001·Biochemical and Biophysical Research Communications·P SaviJ M Herbert
May 23, 2001·JAMA : the Journal of the American Medical Association·P M RidkerN Rifai
Jun 15, 2001·Journal of Thrombosis and Thrombolysis·G Proimos
Jun 20, 2001·Circulation·L K NewbyE J Topol
Jun 23, 2001·The New England Journal of Medicine·E J TopolUNKNOWN TARGET Investigators. Do Tirofiban and ReoPro Give Similar Efficacy Trial
Jun 27, 2001·Lancet·M L Simoons, UNKNOWN GUSTO IV-ACS Investigators
Jul 17, 2001·Platelets·R F Storey